Abstract
Bioerodible polymeric implants have been used for the delivery of a range of anticancer drugs [1–5]. These devices are favorable for clinical use because the device is eliminated from the brain after the drug has been depleted. Most studies have been conducted by Brem and co-workers using poly(l,3-p-carboxyphenoxypropane-sebacic acid) [P(CPP-SA)] as drug carrier [4–11].
| Original language | American English |
|---|---|
| Title of host publication | Blood—Brain Barrier: Drug Delivery and Brain Pathology |
| Editors | David Kobiler, Shlomo Lustig, Shlomo Shapira |
| Place of Publication | Boston, MA |
| Publisher | Springer US; Imprint: Springer |
| Pages | 351-361 |
| Number of pages | 11 |
| ISBN (Print) | 978-1-4615-0579-2 |
| DOIs | |
| State | Published - 2001 |
Fingerprint
Dive into the research topics of 'Synthesis of Poly (Carboxyphenoxypropane-Sebacic Anhydride) for the Delivery of Drugs to the Brain'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver